144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.

Wedemeyer H, Aleman S, Blank A, Andreone P, Bogomolov P, Chulanov V, Mamonova N, Geyvandova N, Morozov V, Sagalova O, Stepanova T, Berger A, Ciesek S, Lichtman A, Manuilov D, Mercier RC, Arterburn S, Christian-Cox F, Tseng S, Osinusi A, Schulze Zur Wiesch J, Cornberg M, Zeuzem S, Brunetto MR, Lampertico P

Open source

DOI: 10.1016/j.jhep.2026.03.046
Published: 2026 Sep
Container: Journal of hepatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2026.03.046,
  title = {144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.},
  author = {Wedemeyer H and Aleman S and Blank A and Andreone P and Bogomolov P and Chulanov V and Mamonova N and Geyvandova N and Morozov V and Sagalova O and Stepanova T and Berger A and Ciesek S and Lichtman A and Manuilov D and Mercier RC and Arterburn S and Christian-Cox F and Tseng S and Osinusi A and Schulze Zur Wiesch J and Cornberg M and Zeuzem S and Brunetto MR and Lampertico P},
  year = {2026},
  journal = {Journal of hepatology},
  doi = {10.1016/j.jhep.2026.03.046},
  url = {https://doi.org/10.1016/j.jhep.2026.03.046}
}

RIS

TY  - JOUR
TI  - 144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.
AU  - Wedemeyer H
AU  - Aleman S
AU  - Blank A
AU  - Andreone P
AU  - Bogomolov P
AU  - Chulanov V
AU  - Mamonova N
AU  - Geyvandova N
AU  - Morozov V
AU  - Sagalova O
AU  - Stepanova T
AU  - Berger A
AU  - Ciesek S
AU  - Lichtman A
AU  - Manuilov D
AU  - Mercier RC
AU  - Arterburn S
AU  - Christian-Cox F
AU  - Tseng S
AU  - Osinusi A
AU  - Schulze Zur Wiesch J
AU  - Cornberg M
AU  - Zeuzem S
AU  - Brunetto MR
AU  - Lampertico P
PY  - 2026
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2026.03.046
UR  - https://doi.org/10.1016/j.jhep.2026.03.046
ER  -

APA

H, W., S, A., A, B., P, A., P, B., V, C., N, M., N, G., V, M., O, S., T, S., A, B., S, C., A, L., D, M., RC, M., S, A., F, C., S, T., A, O., J, S. Z. W., M, C., S, Z., MR, B., & P, L. (2026). 144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.. Journal of hepatology. https://doi.org/10.1016/j.jhep.2026.03.046

Source records

pubmed · retrieved 2026-09-25T20:28:19.774Z